Metaplane Announces $13.8M Series A led by Felicis on Heels of Rapid Growth [Yahoo! Finance]
Guardant Health, Inc. (GH)
Last guardant health, inc. earnings: 2/24 04:03 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
BOSTON March 5, 2024 /PRNewswire/ -- Metaplane , the leading data observability platform for data teams, today announced its $13.8 million Series A funding round led by Felicis , with participation Khosla Ventures, Flybridge, Y Combinator, Stage 2 Capital, B37, and SNR. This comes on the heels of a successful 2023 that saw impressive revenue growth, accelerated customer acquisition, and rapid product innovation. With the close of its Series A round, Metaplane has now raised a total of $22.2 million including its Seed round, which was raised less than one year ago, and includes leading investors like Khosla Ventures, Flybridge, and Y Combinator. Metaplane will use the fresh round of capital to continue building the next evolution of data observability, with the goal of helping data teams monitor data more deeply, easily, and faster than ever before. In 2023, the Metaplane customer base tripled to over 100 companies and now includes the data teams at leading companies like Klaviyo, Sig
Show less
Read more
Impact Snapshot
Event Time:
GH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GH alerts
High impacting Guardant Health, Inc. news events
Weekly update
A roundup of the hottest topics
GH
News
- Guardant Health, Inc. (NASDAQ: GH) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $45.00 to $30.00. They now have a "buy" rating on the stock.MarketBeat
- Guardant Health, Inc. (NASDAQ: GH) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $28.00 price target on the stock.MarketBeat
- Amplifier Security emerges from stealth to bridge divide between the workforce and security with AI copilot and human-in-the-loop automation [Yahoo! Finance]Yahoo! Finance
- Putting The Human Touch Back Into Cybersecurity With Amplifier [Forbes]Forbes
- FDA Advisory Panel Review of Guardant Health's Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23 [Yahoo! Finance]Yahoo! Finance
GH
Earnings
- 2/22/24 - Beat
GH
Sec Filings
- 5/2/24 - Form 4
- 4/25/24 - Form ARS
- 4/25/24 - Form DEFA14A
- GH's page on the SEC website